(Q40579847)

21 September 2017

Immunogenicity of a highly attenuated MVA smallpox vaccine and protection against monkeypox (English)

1 reference

21 September 2017

1 reference

1 reference

0 references

1 reference

18

Bernard Moss

1 reference

21 September 2017

17

Peter B Jahrling

1 reference

21 September 2017

7

Roselyn J Eisenberg

1 reference

21 September 2017

3

Linda S Wyatt

1 reference

21 September 2017

1

Patricia L Earl

1 reference

21 September 2017

13

Eric M Mucker

1 reference

21 September 2017

2

Jeffrey L Americo

1 reference

21 September 2017

16

John W Huggins

1 reference

21 September 2017

4

Leigh Anne Eller

1 reference

21 September 2017

6

Gary H Cohen

1 reference

21 September 2017

12

David M Miller

1 reference

21 September 2017

J Charles Whitbeck

5

1 reference

21 September 2017

Christopher J Hartmann

8

1 reference

21 September 2017

David L Jackson

9

1 reference

21 September 2017

David A Kulesh

10

1 reference

21 September 2017

Mark J Martinez

11

1 reference

21 September 2017

Joshua D Shamblin

14

1 reference

21 September 2017

Susan H Zwiers

15

1 reference

21 September 2017

language of work or name

English

0 references

publication date

1 March 2004

1 reference

21 September 2017

1 reference

21 September 2017

428

1 reference

21 September 2017

182-185

1 reference

21 September 2017

6979

1 reference

https://scigraph.springernature.com/pub.10.1038/nature02331

21 September 2017

0 references

cites work

Smallpox vaccination: a review, part II. Adverse events

1 reference

https://api.crossref.org/works/10.1038%2FNATURE02331

7 January 2021

Mapping of deletions in the genome of the highly attenuated vaccinia virus MVA and their influence on virulence

1 reference

https://api.crossref.org/works/10.1038%2FNATURE02331

7 January 2021

The complete genomic sequence of the modified vaccinia Ankara strain: comparison with other orthopoxviruses

1 reference

https://api.crossref.org/works/10.1038%2FNATURE02331

7 January 2021

Host range and cytopathogenicity of the highly attenuated MVA strain of vaccinia virus: propagation and generation of recombinant viruses in a nonhuman mammalian cell line

1 reference

https://api.crossref.org/works/10.1038%2FNATURE02331

7 January 2021

Highly attenuated modified vaccinia virus Ankara replicates in baby hamster kidney cells, a potential host for virus propagation, but not in various human transformed and primary cells

1 reference

https://api.crossref.org/works/10.1038%2FNATURE02331

7 January 2021

Modified vaccinia virus Ankara undergoes limited replication in human cells and lacks several immunomodulatory proteins: implications for use as a human vaccine

1 reference

https://api.crossref.org/works/10.1038%2FNATURE02331

7 January 2021

Nonreplicating vaccinia vector efficiently expresses recombinant genes

1 reference

https://api.crossref.org/works/10.1038%2FNATURE02331

7 January 2021

Safety of modified vaccinia virus Ankara (MVA) in immune-suppressed macaques.

1 reference

https://api.crossref.org/works/10.1038%2FNATURE02331

7 January 2021

Shared modes of protection against poxvirus infection by attenuated and conventional smallpox vaccine viruses

1 reference

https://api.crossref.org/works/10.1038%2FNATURE02331

7 January 2021

MVA vaccination against smallpox: clinical tests with an attenuated live vaccinia virus strain (MVA) (author's transl)

1 reference

https://api.crossref.org/works/10.1038%2FNATURE02331

7 January 2021

The pathology of experimental aerosolized monkeypox virus infection in cynomolgus monkeys (Macaca fascicularis).

1 reference

https://api.crossref.org/works/10.1038%2FNATURE02331

7 January 2021

Smallpox research activities: U.S. interagency collaboration, 2001

1 reference

https://api.crossref.org/works/10.1038%2FNATURE02331

7 January 2021

Human monkeypox: a newly emerged orthopoxvirus zoonosis in the tropical rain forests of Africa

1 reference

https://api.crossref.org/works/10.1038%2FNATURE02331

7 January 2021

Poxvirus dilemmas--monkeypox, smallpox, and biologic terrorism

1 reference

https://api.crossref.org/works/10.1038%2FNATURE02331

7 January 2021

The formation and function of extracellular enveloped vaccinia virus

1 reference

https://api.crossref.org/works/10.1038%2FNATURE02331

7 January 2021

Antibody neutralization of the extracellular enveloped form of vaccinia virus

1 reference

https://api.crossref.org/works/10.1038%2FNATURE02331

7 January 2021

DNA vaccination with vaccinia virus L1R and A33R genes protects mice against a lethal poxvirus challenge

1 reference

https://api.crossref.org/works/10.1038%2FNATURE02331

7 January 2021

Four-gene-combination DNA vaccine protects mice against a lethal vaccinia virus challenge and elicits appropriate antibody responses in nonhuman primates

1 reference

https://api.crossref.org/works/10.1038%2FNATURE02331

7 January 2021

Neutralizing and protective antibodies directed against vaccinia virus envelope antigens

1 reference

https://api.crossref.org/works/10.1038%2FNATURE02331

7 January 2021

A myristylated membrane protein encoded by the vaccinia virus L1R open reading frame is the target of potent neutralizing monoclonal antibodies

1 reference

https://api.crossref.org/works/10.1038%2FNATURE02331

7 January 2021

Development and use of a vaccinia virus neutralization assay based on flow cytometric detection of green fluorescent protein

1 reference

https://api.crossref.org/works/10.1038%2FNATURE02331

7 January 2021

An antigenic difference between intracellular and extracellular rabbitpox virus

1 reference

https://api.crossref.org/works/10.1038%2FNATURE02331

7 January 2021

Antibody-sensitive and antibody-resistant cell-to-cell spread by vaccinia virus: role of the A33R protein in antibody-resistant spread

1 reference

https://api.crossref.org/works/10.1038%2FNATURE02331

7 January 2021

Diagnosis and management of smallpox

1 reference

https://api.crossref.org/works/10.1038%2FNATURE02331

7 January 2021

Ex vivo detection and enumeration of human antigen-specific CD8+ T lymphocytes using antigen delivery by a recombinant vaccinia expression vector and intracellular cytokine staining

1 reference

https://api.crossref.org/works/10.1038%2FNATURE02331

7 January 2021

Identifiers

DOI

10.1038/NATURE02331

1 reference

Dimensions Publication ID

21 September 2017

0 references

1 reference